Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

被引：16
|
作者：
Rollig, Christoph
Kramer, Michael
Schliemann, Christoph
Mikesch, Jan-Henrik
Steffen, Bjorn
Kramer, Alwin
Sauer, Tim
Hanel, Mathias
Herbst, Regina
Schafer-Eckart, Kerstin
Noppeney, Richard
Jost, Edgar
Brummendorf, Tim H.
Krause, Stefan W.
Kunzmann, Volker
Einsele, Hermann
Scholl, Sebastian
Hochhaus, Andreas
Fransecky, Lars R.
Kaufmann, Martin
Neubauer, Andreas
Niemann, Dirk
Schaich, Markus
Frickhofen, Norbert
Kiani, Alexander
Heits, Frank
Krumpelmann, Ulrich
Kaiser, Ulrich
Kullmer, Johannes
Wass, Maxi
Klein, Stefan
Von Bonin, Malte
Middeke, Jan Moritz
Thiede, Christian
Stoelzel, Friedrich
Schetelig, Johannes
Ehninger, Gerhard
Baldus, Claudia D.
Muller-Tidow, Carsten
Platzbecker, Uwe
Serve, Hubert
Bornhauser, Martin
机构：
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-123717
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13
引用
收藏
页数：6
相关论文
共 50 条
  • [41] How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia
    Brian A. Jonas
    Daniel A. Pollyea
    Leukemia, 2019, 33 : 2795 - 2804
  • [42] How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia
    Jonas, Brian A.
    Pollyea, Daniel A.
    LEUKEMIA, 2019, 33 (12) : 2795 - 2804
  • [43] An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure
    Swan Lin
    Naveed Shaik
    Geoffrey Chan
    Jorge E. Cortes
    Ana Ruiz-Garcia
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 451 - 459
  • [44] Real world outcomes among patients with newly diagnosed acute myeloid leukemia
    Pulte, Elizabeth D.
    Fernandes, Laura L.
    Wynne, Joseph
    Hansen, Eric
    Belli, Andrew J.
    Barcellos, Anna
    Zettler, Christina M.
    Bystrom, Rebecca
    Vallejo, Jonathon
    Gu, Wenjuan
    Lerro, Catherine
    Norsworthy, Kelly
    DeClaro, Angelo
    Theoret, Marc R.
    Rivera, Donna
    Wang, Ching-Kun
    CANCER RESEARCH, 2024, 84 (06)
  • [45] Outcomes of patients with newly diagnosed acute myeloid leukemia (AML) and hyperleukocytosis.
    Haddad, Fadi
    Sasaki, Koji
    Abuasab, Tareq
    Venugopal, Sangeetha
    Rivera, Daniel
    Bazinet, Alexandre
    Babakhanlou, Rodrick
    Kim, Kunhwa
    Senapati, Jayastu
    Ong, Faustine
    Desikan, Sai Prasad
    Short, Nicholas James
    Pemmaraju, Naveen
    Borthakur, Gautam
    Dinardo, Courtney Denton
    Daver, Naval Guastad
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kadia, Tapan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19029 - E19029
  • [46] An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure
    Lin, Swan
    Shaik, Naveed
    Chan, Geoffrey
    Cortes, Jorge E.
    Ruiz-Garcia, Ana
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (04) : 451 - 459
  • [47] The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia
    Liu, Chia-Jen
    Hong, Ying-Chung
    Kuan, Ai Seon
    Yeh, Chiu-Mei
    Tsai, Chun-Kuang
    Liu, Yao-Chung
    Hsiao, Liang-Tsai
    Wang, Hao-Yuan
    Ko, Po-Shen
    Chen, Po-Min
    Liu, Jin-Hwang
    Gau, Jyh-Pyng
    CANCER MEDICINE, 2020, 9 (04): : 1572 - 1580
  • [48] Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia
    Short, Nicholas J.
    Wierzbowska, Agnieszka
    Cluzeau, Thomas
    Laribi, Kamel
    Recher, Christian
    Czyz, Jaroslaw
    Ochrem, Bogdan
    Ades, Lionel
    Gallego-Hernanz, Maria Pilar
    Heiblig, Mael
    Audisio, Ernesta
    Zarzycka, Ewa
    Li, Shuli
    Ferenc, Nicholas
    Yeh, Tammie
    Faller, Douglas V.
    Sedarati, Farhad
    Papayannidis, Cristina
    LEUKEMIA & LYMPHOMA, 2025, 66 (03) : 458 - 468
  • [49] Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment
    Ikezoe, Takayuki
    Usuki, Kensuke
    Aida, Kensuke
    Hatayama, Tomoyoshi
    Shirahase, Toru
    Yamauchi, Takahiro
    CANCER SCIENCE, 2023, 114 (03) : 1037 - 1044
  • [50] Treatment With Leukapheresis In Patients Diagnosed With Hyperleukocytic Acute Myeloid Leukemia
    Martinez-Cuadron, David
    Montesinos, Pau
    Moscardo, Federico
    Lopez, Lineth
    Martin, Guillermo
    Solves, Pilar
    Boluda, Blanca
    Perez-Sirvent, Mariluz
    Vera, Belen
    Navarro, Ines
    Alonso, Carmen M.
    Martinez, Jesus
    Lopez-Chulia, Francisca
    Sanz, Jaime
    Carpio, Nelly
    Rodriguez-Veiga, Rebeca
    Iacoboni, Gloria
    Sanz, Guillermo
    Sanz, Miguel
    BLOOD, 2013, 122 (21)
12345